Brief: Medicinova: Received Notice Of Allowance For New Patent Covering Mn-001 And Mn-002 For Treatment Of Hypertriglyceridemia, Hypercholesterolemia, And Hyperlipoproteinemia In Canada
14/09/2022 24:11
Sept 14 (Reuters) -
* MEDICINOVA: RECEIVED NOTICE OF ALLOWANCE FOR NEW PATENT
COVERING
MN-001 AND MN-002 FOR TREATMENT OF HYPERTRIGLYCERIDEMIA,
HYPERCHOLESTEROLEMIA, AND HYPERLIPOPROTEINEMIA IN CANADA
Further company coverage: MNOV.O
(Reporting by Tokyo Newsroom)
((+81345201189;))
Recent news on Medicinova
See all newsBrief: 3D Investment Partners Cuts Stake In Medicinova To 9.88% From 11.22%, Filing Shows
US STOCKS ON THE MOVE-Mirum Pharmaceuticals, Meta, Boeing
U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, SpaceX
MediciNova falls as fatty liver drug misses significance on blood-fat reduction
US STOCKS ON THE MOVE-WhiteHawk, Nvidia, Snowflake